Surgery
Volume 146, Issue 5 , Pages 906-912 , November 2009

Long-term outcome of “prophylactic therapy” for familial medullary thyroid cancer

  • Elisabeth Schellhaas, MD

      Affiliations

    • Department of Surgery I, Charité Medical School, Campus Benjamin Franklin, Berlin, Germany
  • ,
  • Charlotte König

      Affiliations

    • Department of Surgery I, Charité Medical School, Campus Benjamin Franklin, Berlin, Germany
  • ,
  • Karin Frank-Raue, MD

      Affiliations

    • Private Practice in Endocrinology, Heidelberg, Germany
  • ,
  • Heinz-J. Buhr, MD

      Affiliations

    • Department of Surgery I, Charité Medical School, Campus Benjamin Franklin, Berlin, Germany
  • ,
  • Hubert G. Hotz, MD

      Affiliations

    • Department of Surgery I, Charité Medical School, Campus Benjamin Franklin, Berlin, Germany
    • Corresponding Author InformationReprint requests: Hubert G. Hotz, MD, Charité Medical School, Campus Benjamin Franklin, Department of Surgery I, Hindenburgdamm 30, 12200 Berlin, Germany.

,Accepted 5 June 2009.

References 

  1. Ball DW. Medullary thyroid cancer: therapeutic targets and molecular markers. Curr Opin Oncol. 2007;19:18–23
  2. Fialkowski EA, Moley JA. Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol. 2006;94:737–747
  3. Bugalho MJM, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol. 2005;91:56–60
  4. Quayle FJ, Moley JF. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes. J Surg Oncol. 2005;89:122–129
  5. Raue F, Frank-Raue K. Multiple endocrine neoplasia type 2: 2007 update. Horm Res. 2007;68(Suppl 5):101–104
  6. Frilling A, Weber F, Tecklenborg C, Broelsch CE. Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene. Langenbeck Arch Surg. 2003;388:17–26
  7. Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Surgery. 2007;141:90–95
  8. Chung YJ, Kim HH, Kim HJ, Min YK, Lee MS, Lee MK, et al. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A. Thyroid. 2004;14:813–818
  9. Ramos C, Ojeda D, Cohn D, Wohllk N. Tiroidectomía profiláctica en ninos y jóvenes con cáncer medular tiroideo hereditario: experiencia chilena. Rev Méd Chile. 2005;133:1029–1036
  10. Skinner MA, Moley JA, Dilley WG, Owzar K, DeBenedetti MA, Wells SA. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med. 2005;353:1105–1113
  11. Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T, et al. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol. 2006;155:229–236
  12. Dralle H, Gimm O, Simon D, Frank-Raue K, Görtz G, Niederle B, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg. 1998;22:744–751
  13. Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med. 2003;349:1517–1525
  14. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H. Advances in the management of hereditary medullary thyroid cancer. J Intern Med. 2005;257:50–59
  15. Machens A, Dralle H. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg. 2007;31:957–968
  16. Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg. 1998;22:562–568
  17. Buhr HJ, Mann B. Thyreoidektomie und Lymphadenektomie. Chirurg. 1999;70:987–998
  18. Vitale G, Caraglia M, Ciccarelli A, Lupoli G, Abbruzzese A, Tagliaferri P, et al. Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer. 2001;91:1797–1808
  19. Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, et al. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid. 2005;15:531–544
  20. Machens A, Holzhausen HJ, Thanh PN, Dralle H. Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery. 2003;134:425–431
  21. Heizmann O, Haecker FM, Zumsteg U, Müller B, Oberholzer M, Oertli D. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a. EJSO. 2006;32:98–102
  22. Gill JR, Reyes-Múgica M, Iyengar S, Kidd KK, Touloukian RJ, Smith C, et al. Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy. J Pediatr. 1996;129:459–464
  23. Gimm O, Dralle H. Lymphadenektomie beim Schilddrüsen- und Nebenschilddrüsenkarzinom. Chirurg. 2007;78:182–193
  24. Mann B, Buhr HJ. Lymph node dissection in patients with differentiated thyroid carcinoma—who benefits?. Langenbeck Arch Surg. 1998;383:355–358
  25. Peix JL, Lifante JC. Curages cervicaux et cancers thyroidiens. Ann Chir. 2003;128:468–474
  26. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab. 2003;88:2070–2075
  27. Pelizzo MR, Boschin IM, Bernante P, Toniato A, Piotto A, Pagetta C, et al. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. EJSO. 2007;33:493–497
  28. Machens A, Hoffmann C, Hauptmann S, Dralle H. Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. Eur J Endocrinol. 2007;157:85–93

PII: S0039-6060(09)00324-9

doi: 10.1016/j.surg.2009.06.007

Surgery
Volume 146, Issue 5 , Pages 906-912 , November 2009